June 23, 2020 / 5:42 PM / 20 days ago

BRIEF-Restorbio, Inc. Says Expect To Continue Development Of RTB101 For A Covid-19 Related Indication, With Clinical Data Expected By Q1 2021

June 23 (Reuters) - resTORbio, Inc.:

* RESTORBIO, INC. - EXPECT TO CONTINUE DEVELOPMENT OF RTB101 FOR A COVID-19 RELATED INDICATION, WITH CLINICAL DATA EXPECTED BY Q1 2021 Source text: [bit.ly/2Z01eQh] Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below